Australian-Singaporean regenerative medicine company Osteopore (ASX:OSX) has secured market approval for its orthopaedic products in Singapore and Vietnam and has obtained regulatory clearance from Singapore’s Health Sciences Authority and Vietnam’s Department of Medical Equipment and Construction https://app.sharelinktechnologies.com/announcement/asx/9720d721aecbbeb12f2a5f8ebc617816
LSR
0.011
83.3%
IS3
0.001
-75%
ADY
0.006
50%
ADR
0.004
-33.3%
C7A
0.003
50%
TEG
0.002
-33.3%
AON
0.007
40%
L1M
0.043
-28.3%
GTE
0.011
37.5%
ZMM
0.008
-27.3%
MEG
0.023
35.3%
FIN
0.003
-25%
ALM
0.004
33.3%
MKL
0.015
-25%
FCT
0.016
33.3%
RGL
0.003
-25%
FHS
0.004
33.3%
TYX
0.003
-25%
GLH
0.068
33.3%
VRC
0.003
-25%
GTR
0.004
33.3%
WBE
0.003
-25%
GBZ
0.017
30.8%
GLA
0.007
-22.2%
VR1
0.037
27.6%
NHE
0.019
-20.8%
MTM
0.715
25.4%
ADG
0.004
-20%
AAU
0.005
25%
MEM
0.004
-20%
CTN
0.005
25%
SKK
0.004
-20%
SIS
0.005
25%
VEN
0.004
-20%
THR
0.011
22.2%
SRL
0.805
-18.7%
KNB
0.039
21.9%
HIQ
0.014
-17.6%
RPG
0.063
21.2%
EM2
0.005
-16.7%
